GRAL Stock Analysis: Buy, Sell, or Hold?
GRAL - GRAIL, Inc. Common Stock
$46.90
-1.59 (-3.28%)
ā¼
5d:
-4.54%
30d:
-11.89%
90d:
-48.79%
BUY
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 12, 2026
Smart Money Accumulation
GRAL is down 8.2% this week, but smart money is accumulating calls. Top strike: $50 2026-04-17 with 1,559 OI. Call ratio: 78% View Scanner →
Strength: 6.9/10
Get Alerted When GRAL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
š” BUY OPPORTUNITY: GRAL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
š” BUY OPPORTUNITY: GRAL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: GRAL is currently trading at $46.90, which is considered fair relative to its 30-day fair value range of $41.07 to $61.53.
Technical Outlook: Technically, GRAL is in a strong downtrend. The price is currently testing key support at $45.71. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $72.40 (+54.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GRAL is in a strong downtrend. The price is currently testing key support at $45.71. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $72.40 (+54.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$41.07 -
$61.53
Company Quality Score
51/100
(HOLD)
Options IV Signal
30th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
69.6%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 30th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 54.4% below Wall St target ($72.40)
Fair Price Analysis
30-Day Fair Range
$41.07 -
$61.53
Current vs Fair Value
FAIR
Expected Move (7 Days)
Ā±$6.30
(13.4%)
Support & Resistance Levels
Support Level
$45.71
Resistance Level
$53.44
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.18
Wall Street Target
$72.40
(+54.4%)
Revenue Growth (YoY)
14.0%
Profit Margin
-277.5%
Share & Embed Analysis
Last updated: March 30, 2026 6:17 PM ET
Data refreshes hourly during market hours. Next update: 7:17 PM
Data refreshes hourly during market hours. Next update: 7:17 PM
š„ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRAL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
14
Sells
Net
INSIDERS SELLING
Recent Transactions
Joshua J Ofman
SELL
2937 shares
2026-03-09
Robert P Ragusa
SELL
7461 shares
2026-03-09
Aaron Freidin
SELL
2492 shares
2026-03-09
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientificā¦ |
STRONG BUY
31 analysts |
$664 | 60 BUY |
|
EXAS
EXACT Sciences Corporatiā¦ |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 61 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 54 HOLD |
Advanced GRAL Option Strategies
Professional options setups generated by AI based on today's GRAL price and gamma walls.
